Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma
Yulong Chen(Wuhan Polytechnic University), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center), Daniela Paňková(The University of Texas MD Anderson Cancer Center), Carmen Behrens, Jaime Rodriguez‐Canales(National Cancer Institute), Masahiko Terajima(University of North Carolina at Chapel Hill), Alan R. Burns(University of Houston), Min P. Kim(Houston Methodist), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Debananda Pati(Children's Cancer Center), Daniel S. Puperi(Rice University), Nishan Thilaganathan(The University of Texas MD Anderson Cancer Center), K. Jane Grande‐Allen(Rice University), Chad J. Creighton(Baylor College of Medicine), Takeshi Watanabe(Wesleyan University), Li Sun(Centre for Inflammation Research), Shanda H. Blackmon(The University of Texas MD Anderson Cancer Center), Tomasz Żal(The University of Texas MD Anderson Cancer Center), Johannah Sanchez‐Adams(Duke Medical Center), Farshid Guilak(Washington University in St. Louis), Hui Liu(Shanghai University), Yanan Yang(Shanghai Medical College of Fudan University), Elisabeth D. Martínez(Southwestern Medical Center), Mitsuo Yamauchi(University of North Carolina at Chapel Hill), Young‐Ho Ahn(Ewha Womans University), Kenneth L. Scott(Dana-Farber Cancer Institute), Rosalba Minelli(Baylor College of Medicine)
Cited by 189
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k